Downregulation of Bcl-xL and Mcl-1 is sufficient to induce cell death in mesothelioma cells highly refractory to conventional chemotherapy.
about
Functional characterization of CLPTM1L as a lung cancer risk candidate gene in the 5p15.33 locusTargeting BCL2-Proteins for the Treatment of Solid TumoursDiscovery of Potent Myeloid Cell Leukemia 1 (Mcl-1) Inhibitors Using Fragment-Based Methods and Structure-Based DesignSimultaneous knock-down of Bcl-xL and Mcl-1 induces apoptosis through Bax activation in pancreatic cancer cellsZoledronic acid overcomes chemoresistance and immunosuppression of malignant mesotheliomaThe role of interleukin-6 in malignant mesotheliomaLipoic acid decreases Mcl-1, Bcl-xL and up regulates Bim on ovarian carcinoma cells leading to cell death.Fucoidan extract enhances the anti-cancer activity of chemotherapeutic agents in MDA-MB-231 and MCF-7 breast cancer cellsChemical perturbation of Mcl-1 pre-mRNA splicing to induce apoptosis in cancer cells.MicroRNA-302b targets Mcl-1 and inhibits cell proliferation and induces apoptosis in malignant pleural mesothelioma cellsInhibition of Mcl-1 expression by citrate enhances the effect of Bcl-xL inhibitors on human ovarian carcinoma cells.The anti-apoptotic members of the Bcl-2 family are attractive tumor-associated antigens.Targeted therapy vs. DNA-adduct formation-guided design: thoughts about the future of metal-based anticancer drugs.ABT-737, Synergistically Enhances Daunorubicin-Mediated Apoptosis in Acute Myeloid Leukemia Cell Lines.Platinum compounds sensitize ovarian carcinoma cells to ABT-737 by modulation of the Mcl-1/Noxa axis.Experimental results using 3-bromopyruvate in mesothelioma: in vitro and in vivo studies.Inhibition of glutathione synthesis reverses Krüppel-like factor 4-mediated cisplatin resistance.Inhibition of the angiogenesis and growth of Aloin in human colorectal cancer in vitro and in vivo.Atelocollagen-mediated in vivo siRNA transfection in ovarian carcinoma is influenced by tumor site, siRNA target and administration route.Small molecule inhibitor TW-37 is tolerable and synergistic with chemotherapy in nasopharyngeal carcinoma.
P2860
Q21134596-7C446E02-75D5-4A74-875D-3071A2EDD015Q26853686-51BA368A-4053-4C64-B6DC-C1854D6E262BQ27675512-DE214419-087A-473D-9FBF-C4FD80D366C8Q34953963-A9648503-243F-4BDD-BA7C-A06858162365Q35176037-947BD71A-285B-4F4E-8AC6-5B43073356F0Q35200628-B2031BC2-98A0-4FAC-91F7-0C8B49C6764FQ35750142-DE787F3C-1F13-4947-8984-724B0A592194Q36586987-E1A2A09A-8EF7-4EAF-AB15-11FEB43F670AQ36853190-30932ADE-A7EB-4836-9674-42A709DFE3BDQ37298299-88AB9134-C6FC-4671-9186-8EC2BFBF61FDQ37365582-A7B319EC-4A62-421E-B666-7E42D345A981Q37838167-9DD1C433-4382-46D1-962C-9DA39235AC60Q38011996-53CFFE01-3F85-48A2-8D25-0830249808F8Q39025514-D3454A06-D106-4919-B46A-8740AE4C4890Q39205781-6F217F33-F1B0-4292-89D2-73D496E5ADE9Q39398646-5EA3E866-001E-4C55-AD95-491796C4CEA8Q39491934-F3745E41-9715-4CE6-B142-557471325D9CQ42051818-3E5A24A9-2702-4B5D-BAD1-31565FF6AA24Q45826092-B882881C-8E06-4FC8-B4C3-728328539C66Q50897221-21B72B1B-2848-48E3-80AF-F349ACDAAD99
P2860
Downregulation of Bcl-xL and Mcl-1 is sufficient to induce cell death in mesothelioma cells highly refractory to conventional chemotherapy.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Downregulation of Bcl-xL and M ...... to conventional chemotherapy.
@en
Downregulation of Bcl-xL and M ...... to conventional chemotherapy.
@nl
type
label
Downregulation of Bcl-xL and M ...... to conventional chemotherapy.
@en
Downregulation of Bcl-xL and M ...... to conventional chemotherapy.
@nl
prefLabel
Downregulation of Bcl-xL and M ...... to conventional chemotherapy.
@en
Downregulation of Bcl-xL and M ...... to conventional chemotherapy.
@nl
P2093
P2860
P356
P1433
P1476
Downregulation of Bcl-xL and M ...... to conventional chemotherapy.
@en
P2093
Christophe Denoyelle
Didier Goux
Edwige Abeilard
Emilie Brotin
Emilie Varin
Florence Giffard
Laurent Poulain
Matthieu Meryet-Figuière
Pascal Gauduchon
Philippe Icard
P2860
P304
P356
10.1093/CARCIN/BGQ026
P407
P577
2010-02-08T00:00:00Z